Manipulation of host resistance in cancer therapy.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000912:Antibodies, Neoplasm / Q000096:biosynthesis / Q000276:immunology; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm / Q000276:immunology; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D007109:Immunity; D007110:Immunity, Active; D007167:Immunotherapy; D007694:Killer Cells, Natural / Q000276:immunology; D008262:Macrophage Activation; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001500:BCG Vaccine